Results overview: Found 21 records in 0.03 seconds.
Articles, 21 records found
Articles 21 records found  1 - 10nextend  jump to record:
1.
13 p, 471.4 KB Overall Survival with Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial / Dimopoulos, Meletios (National and Kapodistrian University of Athens) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nahi, Hareth (Department of Medicine. Karolinska University) ; San-Miguel, J (Clínica Universidad de Navarra) ; Bahlis, Nizar J. (University of Calgary) ; Usmani, S. Z (Memorial Sloan Kettering Cancer Center) ; Rabin, Neil (Department of Haematology. University College London Hospitals NHS Trust) ; Orlowski, Robert Z. (Department of Lymphoma and Myeloma. The University of Texas) ; Suzuki, Kenshi (Department of Hematology. Japanese Red Cross Medical Center) ; Plesner, Torben (University of Southern Denmark) ; Yoon, Sung Soo (Department of Internal Medicine. Seoul National University) ; Ben Yehuda, Dina (Hematology Department. Hebrew University) ; Richardson, Paul G. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ; Goldschmidt, Hartmut (University Hospital Heidelberg) ; Reece, Donna (Department of Medical Oncology and Hematology. Princess Margaret Cancer Centre) ; Ahmadi, Tahamtan (Genmab US (Estats Units d'Amèrica)) ; Qin, Xiang (Janssen Research & Development (Xina)) ; Garvin Mayo, Wendy (Janssen Research & Development (Estats Units d'Amèrica)) ; Gai, Xue (Janssen Research & Development (Estats Units d'Amèrica)) ; Carey, Jodi (Janssen Research & Development (Estats Units d'Amèrica)) ; Carson, Robin (Janssen Research & Development (Estats Units d'Amèrica)) ; Moreau, Philippe (Hematology Department. University Hospital Hôtel-Dieu)
PURPOSEWith the initial analysis of POLLUX at a median follow-up of 13. 5 months, daratumumab in combination with lenalidomide and dexamethasone (D-Rd) significantly prolonged progression-free survival versus lenalidomide and dexamethasone (Rd) alone in patients with relapsed or refractory multiple myeloma (RRMM). [...]
2023 - 10.1200/JCO.22.00940
Journal of Clinical Oncology, Vol. 41 Núm. 8 (october 2023) , p. 1590-1599  
2.
10 p, 876.7 KB Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease : a comparison of assessment instruments / Horta, Andrea (Universitat Autònoma de Barcelona. Departament de Medicina) ; Martinez-Horta, Saul (Universitat Autònoma de Barcelona. Departament de Medicina) ; Pérez-Pérez, Jesús (Universitat Autònoma de Barcelona. Departament de Medicina) ; Puig-Davi, Arnau (Institut d'Investigació Biomèdica Sant Pau) ; de Lucia, Natascia (University of Naples "Federico II", Naples, Italy) ; de Michele, Giuseppe (University of Naples "Federico II", Naples, Italy) ; Salvatore, Elena (University of Naples "Federico II", Naples, Italy) ; Kehrer, Stefanie (Charité-Universitätsmedizin, Berlin, Germany) ; Priller, Josef (Charité-Universitätsmedizin, Berlin, Germany) ; Migliore, Simone (Fondazione IRCCS Casa Sollievo Della Sofferenza Research Hospital, San Giovanni Rotondo, Italy) ; Squitieri, Ferdinando (Fondazione IRCCS Casa Sollievo Della Sofferenza Research Hospital, San Giovanni Rotondo, Italy) ; Castaldo, Ana (Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy) ; Mariotti, Caterina (Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy) ; Mañanes, Verónica (Hospital Universitario Ramon Y Cajal) ; Lopez-Sendon, José Luís (Hospital Universitario Ramon Y Cajal) ; Rodriguez, Noelia (Fundación Jimenez Diaz) ; Martinez-Descals, Asunción (Fundación Jimenez Diaz) ; Júlio, Filipa (Coimbra University Hospital) ; Januário, Cristina (Coimbra University Hospital) ; Delussi, marianna (European Huntington's Disease Network (EHDN), Ulm, Germany) ; de Tommaso, Marina (European Huntington's Disease Network (EHDN), Ulm, Germany) ; Noguera, Sandra (Hospital Mare de Deu de La Mercè) ; Ruiz-Idiago, Jesús (Hospital Mare de Deu de La Mercè) ; Sitek, Emilia J. (St. Adalbert Hospital, Copernicus, Gdańsk, Poland) ; Wallner, Renata (Medical University of Wroclaw, Wroclaw, Poland) ; Nuzzi, Angela (European Huntington's Disease Network (EHDN), Ulm, Germany) ; Pagonabarraga Mora, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Kulisevsky, Jaime (Universitat Autònoma de Barcelona. Departament de Medicina)
Background: Progressive cognitive decline is an inevitable feature of Huntington's disease (HD) but specific criteria and instruments are still insufficiently developed to reliably classify patients into categories of cognitive severity and to monitor the progression of cognitive impairment. [...]
2023 - 10.1007/s00415-023-11804-0
Journal of Neurology, Vol. 270, Num. 11 (november 2023) , p. 5408-5417  
3.
14 p, 762.0 KB Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis : Results from ASCLEPIOS I and II / Gärtner, Jutta (University Medical Centre Göttingen) ; Hauser, Stephen L. (University of California, San Francisco) ; Bar-Or, Amit (University of Pennsylvania) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cohen, Jeffrey A. (Cleveland Clinic Foundation) ; Cross, Anne H. (Washington University School of Medicine) ; Deiva, Kumaran (University Hospitals Paris Saclay) ; Ganjgahi, Habib (University of Oxford) ; Häring, Dieter A. (Novartis) ; Li, Bingbing (Novartis) ; Pingili, Ratnakar (Novartis) ; Ramanathan, Krishnan (Novartis) ; Su, Wendy (Novartis) ; Willi, Roman (Novartis) ; Kieseier, Bernd (Novartis) ; Kappos, Ludwig (University of Basel) ; Universitat Autònoma de Barcelona
Background: In the phase III ASCLEPIOS I and II trials, participants with relapsing multiple sclerosis receiving ofatumumab had significantly better clinical and magnetic resonance imaging (MRI) outcomes than those receiving teriflunomide. [...]
2022 - 10.1177/13524585221078825
Multiple sclerosis, Vol. 28 Núm. 10 (2022) , p. 1562-1575  
4.
9 p, 341.7 KB Risk of requiring a wheelchair in primary progressive multiple sclerosis : Data from the ORATORIO trial and the MSBase registry / Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Butzkueven, Helmut (Monash University) ; Spelman, Tim (University of Melbourne) ; Horakova, Dana (Charles University. Faculty of Medicine in Hradec Králové) ; Hughes, Stella (Craigavon Area Hospital) ; Solaro, Claudio Marcello (CRRF "Mons. Luigi Novarese") ; Izquierdo, Guillermo (Hospital Vithas Nisa) ; Kubala Havrdova, Eva (Charles University) ; Grand'Maison, Francois (Neuro Rive-Sud) ; Prat, Alexandre (Universite de Montreal) ; Girard, Marc (Universite de Montreal) ; Hupperts, Raymond (Zuyderland Ziekenhuis) ; Onofrj, Marco (University G. d'Annunzio) ; Lugaresi, Alessandra (UOSI Riabilitazione Sclerosi Multipla) ; Taylor, Bruce (Royal Hobart Hospital) ; Giovannoni, Gavin (Queen Mary University of London) ; Kappos, Ludwig (University of Basel) ; Hauser, Stephen L. (University of California) ; Craveiro, Licinio (F. Hoffmann-La Roche Ltd) ; Freitas, Rita (F. Hoffmann-La Roche Ltd) ; Model, Fabian (F. Hoffmann-La Roche Ltd) ; Overell, James (F. Hoffmann-La Roche Ltd) ; Muros-Le Rouzic, Erwan (F. Hoffmann-La Roche Ltd) ; Sauter, Annette (F. Hoffmann-La Roche Ltd) ; Wang, Qing (F. Hoffmann-La Roche Ltd) ; Wormser, David (F. Hoffmann-La Roche Ltd) ; Wolinsky, Jerry S. (McGovern Medical School) ; MSBase Study Group ; Universitat Autònoma de Barcelona
Background and purpose: Reaching Expanded Disability Status Scale (EDSS) ≥7. 0 represents the requirement for a wheelchair. Here we (i) assess the effect of ocrelizumab on time to EDSS ≥7. 0 over the ORATORIO (NCT01194570) double-blind and extended controlled periods (DBP+ECP), (ii) quantify likely long-term benefits by extrapolating results, and (iii) assess the plausibility of extrapolations using an independent real-world cohort (MSBase registry; ACTRN12605000455662). [...]
2022 - 10.1111/ene.14824
European Journal of Neurology, Vol. 29 Núm. 4 (2022) , p. 1082-1090  
5.
23 p, 654.2 KB Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020 Documento de consenso de poliquistosis renal autosómica dominante del grupo de trabajo de enfermedades hereditarias de la Sociedad Española de Nefrología. Revisión 2020 / Ars, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Bernis, C. (Hospital Universitario de la Princesa (Madrid)) ; Fraga Rodríguez, Gloria María (Institut d'Investigació Biomèdica Sant Pau) ; Furlano, Monica (Institut d'Investigació Biomèdica Sant Pau) ; Martínez, V. (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Martins, J. (Servicio de Nefrología. Hospital Universitario de Getafe. Universidad Europea de Madrid) ; Ortiz, A. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Pérez-Gómez, M.V. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Rodríguez-Pérez, J.C. (Hospital Universitario de Gran Canaria Dr. Negrín) ; Sans, L. (Hospital del Mar (Barcelona, Catalunya)) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent cause of genetic renal disease and accounts for 6-10% of patients on kidney replacement therapy (KRT). Very few prospective, randomized trials or clinical studies address the diagnosis and management of this relatively frequent disorder. [...]
2022 - 10.1016/j.nefroe.2022.11.011
Nefrología (Badalona. English), Vol. 42 Núm. 4 (enero 2022) , p. 367-389  
6.
10 p, 599.4 KB Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound / Segarra, S. (RandD Bioiberica S.A.U) ; Miró, G. (Universidad Complutense de Madrid. Facultad de Veterinaria) ; Montoya, A. (Universidad Complutense de Madrid. Facultad de Veterinaria) ; Pardo-Marín, Luis (Universidad de Murcia. Laboratorio Interdisciplinario de Análisis Clínicos Interlab) ; Teichenné, J. (Eurecat - Health and Nutrition Unit) ; Ferrer i Caubet, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Cerón, José Joaquín (Universidad de Murcia. Laboratorio Interdisciplinario de Análisis Clínicos Interlab)
Background: The prevalence of Leishmania infantum infection in clinically healthy dogs can be several times higher than that of clinical disease in endemic areas. Although treatment is not recommended in dogs with subclinical infection, these animals should be managed to prevent disease progression and parasite transmission to human beings or to other dogs. [...]
2018 - 10.1186/s13071-018-2705-z
Parasites & vectors, Vol. 11 Núm. 1 (21 2018) , p. 103  
7.
6 p, 488.2 KB Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease : Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial / Maher, Toby M. (National Heart and Lung Institute. Imperial College London and NIHR Clinical Research Facility. Royal Brompton Hospital. London. UK. and Keck School of Medicine. University of Southern California) ; Mayes, Maureen D. (University of Texas McGovern Medical School) ; Kreuter, Micahel (Thoraxklinik. University of Heidelberg. and the German Center for Lung Research) ; Volkmann, Elizabeth R. (University of California. David Geffen School of Medicine) ; Aringer, Martin (University Medical Center and Faculty of Medicine Carl Gustav Carus. TU Dresden) ; Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Cutolo, Maurizio (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ; Stock, Christian (Boehringer Ingelheim Pharma GmbH & Co. KG) ; Schoof, Nils (Boehringer Ingelheim International GmbH. Ingelheim am Rhein) ; Alves, Margarida (Boehringer Ingelheim International GmbH. Ingelheim am Rhein) ; Raghu, Ganesh (University of Washington)
Objective: In the SENSCIS trial in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD), nintedanib reduced the rate of decline in forced vital capacity (FVC) over 52 weeks by 44% versus placebo. [...]
2021 - 10.1002/art.41576
Arthritis and Rheumatology, Vol. 73 Núm. 4 (april 2021) , p. 671-676  
8.
12 p, 2.7 MB Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale / Jacobs, M.B. (Pediatrics. Epidemiology. and Biostatistics. George Washington University) ; James, Meredith K (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ; Lowes, Linda P (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ; Alfano, Lindsay N (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ; Eagle, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ; Muni Lofra, R. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ; Moore, U. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ; Feng, J. (Center for Translational Science. Division of Biostatistics and Study Methodology. Children's National Health System) ; Rufibach, L.E. (The Jain Foundation) ; Rose, K. (The Children's Hospital at Westmead. The University of Sydney) ; Duong, T. (Lucile Salter Packard Children's Hospital at Stanford) ; Bello, Luca (Department of Neuroscience. University of Padova) ; Pedrosa-Hernández, Irene (Institut d'Investigació Biomèdica Sant Pau) ; Holsten, Scott (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ; Sakamoto, C. (Department of Physical Rehabilitation. National Center Hospital. National Center of Neurology and Psychiatry) ; Canal, Aurélie (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ; Sanchez-Aguilera Práxedes, N. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Thiele, S. (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians University of Munich) ; Siener, C. (Department of Neurology Washington University School of Medicine) ; Vandevelde, B. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ; DeWolf, Brittney (Cooperative International Neuromuscular Research Group (CINRG). Children's National Health System) ; Maron, E. (ELAN-PHYSIO. Praxis für Physiotherapie Maron) ; Guglieri, M. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ; Hogrel, J.Y. (Institut de Myologie (París, França)) ; Blamire, Andrew (Magnetic Resonance Centre. Institute for Cellular Medicine. Newcastle University) ; Carlier, Pierre G (AIM & CEA NMR Laboratory. Institute of Myology. Pitié-Salpêtrière University Hospital) ; Spuler, S. (Charite Muscle Research Unit. Experimental and Clinical Research Center. a joint cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine) ; Day, John W (Department of Neurology and Neurological Sciences. Stanford University School of Medicine) ; Jones, K.J. (The Children's Hospital at Westmead. The University of Sydney) ; Bharucha-Goebel, Diana (National Institutes of Health (Bethesda, Estats Units d'Amèrica)) ; Salort-Campana, E. (Service des Maladies Neuromusculaire et de la SLA. Hôpital de La Timone) ; Pestronk, Alan (Washington University School of Medicine) ; Walter, Maggie C (Friedrich-Baur-Institute. Department of Neurology. Ludwig-Maximilians University of Munich) ; Paradas, C. (Instituto de Biomedicina de Sevilla) ; Stojkovic, T. (Institut de Myologie. AP-HP. GH Pitié-Salpêtrière) ; Mori-Yoshimura, Madoka (National Center of Neurology and Psychiatry Tokyo) ; Bravver, Elena (Neuroscience Institute. Carolinas Neuromuscular/ALS-MDA Center. Carolinas HealthCare System) ; Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Pegoraro, Elena (University of Padova) ; Mendell, J. R. (The Abigail Wexner Research Institute at Nationwide Children's Hospital) ; Mayhew, A.G. (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway) ; Straub, Volker (The John Walton Muscular Dystrophy Research Centre. Translational and Clinical Research Institute. Newcastle University and Newcastle Hospitals NHS Foundation Trust. Central Parkway)
Objective: Dysferlinopathy is a muscular dystrophy with a highly variable clinical presentation and currently unpredictable progression. This variability and unpredictability presents difficulties for prognostication and clinical trial design. [...]
2021 - 10.1002/ana.26044
Annals of neurology, Vol. 89 Núm. 5 (may 2021) , p. 967-978  
9.
25 p, 1.1 MB Predictors of global non-motor symptoms burden progression in parkinson's disease. Results from the coppadis cohort at 2-year follow-up / Santos García, Diego (Complejo Hospitalario Universitario de A Coruña) ; de Deus Fonticoba, Teresa (Complejo Hospitalario Universitario de Ferrol) ; Cores Bartolomé, Carlos (Complejo Hospitalario Universitario de A Coruña) ; Canfield Medina, H (Complejo Hospitalario Universitario de Ferrol) ; Paz González, Jose M. (Complejo Hospitalario Universitario de A Coruña) ; Martínez Miró, Cristina (Complejo Hospitalario Universitario de A Coruña) ; Valdés Aymerich, Lorena (Complejo Hospitalario Universitario de A Coruña) ; Suárez, Ester (Complejo Hospitalario Universitario de Ferrol) ; Jesús, Silvia (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Aguilar Barberà, Miquel (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Pastor, Pau (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Planellas, Lluís (Hospital Clínic i Provincial de Barcelona) ; Cosgaya, Marina (Hospital Clínic i Provincial de Barcelona) ; García Caldentey, Juan (Centro Neurológico Oms 42) ; Caballol, Nuria (Hospital de Sant Joan Despí Moisès Broggi) ; Legarda, Inés (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Hernández-Vara, Jorge (Hospital Universitari Vall d'Hebron) ; Cabo-Lopez, Iria (Complejo Hospitalario Universitario de Pontevedra) ; López Manzanares, Lydia (Hospital Universitario de la Princesa (Madrid)) ; Gonzalez-Aramburu, Isabel. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Ávila Rivera, Maria A. (Consorci Sanitari Integral. Hospital General de L'Hospitalet) ; Catalán, Maria J. (Hospital Universitario Clínico San Carlos (Madrid)) ; Nogueira, Victor (Hospital Da Costa) ; Puente, Victor (Hospital del Mar (Barcelona, Catalunya)) ; Dotor, Julio (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Borrué, Carmen (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ; Solano Vila, Berta (Institut Català de la Salut) ; Álvarez Sauco, María (Hospital General Universitario de Elche) ; Vela, Lydia (Hospital Universitario Fundación Alcorcón) ; Escalante, Sonia (Hospital de Tortosa Verge de la Cinta) ; Cubo, Esther (Complejo Asistencial Universitario de Burgos) ; Carrillo, Francisco (Hospital Universitario de Canarias (La Laguna)) ; Martínez-Castrillo, Juan Carlos (Hospital Universitario Ramón y Cajal (Madrid)) ; Sánchez Alonso, Pilar (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Alonso, Gemma (Hospital Álvaro Cunqueiro (Vigo)) ; López Ariztegui, Nuria (Complejo Hospitalario de Toledo) ; Gastón, Itziar (Complejo Hospitalario de Navarra) ; Kulisevsky, Jaime (Institut d'Investigació Biomèdica Sant Pau) ; Blázquez Estrada, Marta (Hospital Universitario Central de Asturias) ; Seijo, Manuel (Complejo Hospitalario Universitario de Pontevedra) ; Rúiz Martínez, Javier (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Valero, Caridad (Hospital Arnau de Vilanova (València)) ; Kurtis, Monica (Hospital Ruber Internacional) ; Fàbregues-Boixar i Nebot, Oriol de (Hospital Universitari Vall d'Hebron) ; Ardura, Jessica (Hospital Universitario de Cabueñes (Gijón)) ; Alonso, Ruben (Hospital Universitario Lucus Augusti (Lugo)) ; Ordás, Carlos (Hospital Universitario Rey Juan Carlos (Madrid)) ; López Díaz, Luis M. (Complejo Hospitalario Universitario de Ourense) ; McAfee, Darrian (Laboratory for Cognition and Neural Stimulation. Univeristy of Pennsylvania) ; Martinez-Martin, Pablo (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Mir, Pablo (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas)
Background and Objective: Non-motor symptoms (NMS) progress in different ways between Parkinson's disease (PD) patients. The aim of the present study was to (1) analyze the change in global NMS burden in a PD cohort after a 2-year follow-up, (2) to compare the changes with a control group, and (3) to identify predictors of global NMS burden progression in the PD group. [...]
2021 - 10.3390/jpm11070626
Journal of Personalized Medicine, Vol. 11 Núm. 7 (july 2021) , p. 626  
10.
17 p, 1.5 MB A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA) : Rationale, Design, and Baseline Data / Pagano, Gennaro (F Hoffmann-La Roche AG Research and Development Division) ; Boess, Frank (Roche Pharma Research and Early Development) ; Taylor, Kirsten I. (Faculty of Psychology. University of Basel) ; Ricci, Benedicte (Roche Pharma Research and Early Development) ; Mollenhauer, Brit ; Poewe, Werner ; Boulay, Anne ; Anzures-Cabrera, Judith (Roche Products Ltd) ; Vogt, Annamarie ; Marchesi, Maddalena ; Post, Anke ; Nikolcheva, Tania ; Kinney, Gene G. (Prothena Biosciences Inc. South San Francisco) ; Zago, Wagner M. ; Ness, Daniel K. ; Svoboda, Hanno (F. Hoffmann-La Roche) ; Britschgi, Markus ; Ostrowitzki, Susanne ; Simuni, Tanya ; Marek, Kenneth (Institute for Neurodegenerative Disorders) ; Koller, Martin ; Sevigny, Jeff ; Doody, Rachelle ; Fontoura, Paulo ; Umbricht, Daniel ; Bonni, Azad ; Altendorf, Claudia ; Anandan, Chareyna ; Andrews, Giulia ; Ansquer, Solène ; Arrouasse, Raphaele ; Aslam, Sana ; Azulay, Jean-Philippe ; Baker, Jeanette ; Balaguer Martinez, Ernest ; Barbu, Shadi ; Bardram, Kara ; Bega, Danny ; Bejr-kasem, Helena (Institut d'Investigació Biomèdica Sant Pau) ; Benatru, Isabelle ; Benchetrit, Eve ; Bernhard, Felix ; Besharat, Amir ; Bette, Sagari ; Bichon, Amelie ; Billnitzer, Andrew ; Blondeau, Sophie ; Boraud, Thomas ; Borngräber, Freiderike ; Boyd, James ; Brockmann, Kathrin ; Brodsky, Matthew ; Brown, Ethan ; Bruecke, Christof ; Calvas, Fabienne ; Canelo, Monica ; Carbone, Federico ; Carroll, Claire ; Casado Fernandez, Laura ; Cassé-Perrot, Catherine ; Castrioto, Anna ; Catala, Helene ; Chan, Justine ; Cheriet, Samia ; Ciabarra, Aanthony ; Classen, Joseph ; Coleman, Juliana ; Coleman, Robert ; Compta, Yaroslau ; Corbillé, Anne-Gaëlle ; Corvol, Jean-Christophe ; Cosgaya, Marina ; Dahodwala, Nabila ; Damier, Philippe ; David, Elodie ; Davis, Thomas ; Dean, Marissa ; Debilly, Berengere ; DeGiorgio, Janell ; Deik, Andres ; Delaby, Laure ; Delfini, Marie-Helene ; Derkinderen, Pascal ; Derost, Philipp ; de Toledo, María ; Deuel, Lisa ; Diaz-Hernandez, Ann Marie ; Dietiker, Cameron ; Dimenshteyn, Karina ; Dotor, Julio ; Durif, Franck ; Ebentheuer, Jens ; Eggert, Karla Maria ; Eichau Madueño, Sara ; Eickhoff, Claudia ; Ellenbogen, Aaron ; Ellmerer, Philipp ; Esparragosa Vazquez, Inés ; Eusebio, Alexandre ; Ewert, Siobhan ; Fang, John ; Feigenbaum, Danielle ; Fluchere, Frederique ; Foubert-Samier, Alexandra ; Fournier, Marie ; Fradet, Anne ; Fraix, Valerie ; Frank, Samuel ; Fries, Franca ; Galitzky, Monique ; Gallardo Pérez, Marisol ; Moreno, Jose Manuel García ; Gasca, Carmen ; Gasser, Thomas ; Gibbons, Joyce ; Giordana, Caroline ; González Martinez, Alicia ; Goodman, Ira ; Gorospe, Arantza ; Goubeaud, Marie ; Grabli, David ; Graziella, Mangone ; Grimaldi, Stephan ; Gross, Jeffrey ; Guimaraes-Costa, Raquel ; Hartmann, Andreas ; Hartmann, Christian ; Hassell, Travis ; Hauser, Robert ; Hernandez, Antonio ; Hernández-Vara, Jorge ; Hoeglinger, Günter ; Homedes, Christian ; Horta, Andrea ; Houeto, Jean-Luc ; Huebl, Julius ; Hui, Jennifer ; Isaacson, Stuart ; Jankovic, Joseph ; Janzen, Annette ; Jauregui, Junior ; Jiao, Jocelyne ; Martí Domenech, María José ; Joseph, Xavier ; Kadimi, Srinath ; Kaminski, Pat ; Kannenberg, Silja ; Kassubek, Jan ; Katz, Maya ; Klos, Kevin ; Klos, Shannon ; Kobet, Christopher ; Koebert, Jennifer ; Krause, Patricia ; Kuehn, Andrea ; Kulisevsky, Jaime (Institut d'Investigació Biomèdica Sant Pau) ; Kumar, Rajeev ; Kunz, Martin ; Kurvits, Lille ; Kwei, Kimberly ; Laganiere, Simon ; Laurens, Brice ; Levin, Johannes ; Levy, Oren ; LeWitt, Peter ; Cristóbal, Gurutz Linazasoro ; Litvan, Irene ; Lizarraga, Karlo ; Longardner, Katherine ; Lopez, Rocío ; López Manzanares, Lydia ; Lucas del Pozo, Sara ; Luquín Pulido, María Rosario ; Luthra, Nijee ; Lyons, Kelly ; Maass, Sylvia ; Machetanz, Gerrit ; Macías, Yolanda ; Maltete, David ; Manez Miro, Jorge Uriel ; Mariani, Louise-Laure ; Marin, Juan ; Marini, Kathrin ; Marques, Ana ; Marti, Gloria ; Martí Domenech, María José ; Martinez, Saul ; Meissner, Wassilios ; Meoni, Sara ; Mollenhauer, Brit ; Martinez, Dunia Mon ; Moon, Johnson ; Moro, Elena ; Morrison, Peter ; Muehlberg, Christoph ; Multani, Manpreet ; Murphy, Christine ; Nicholas, Anthony ; Pahwa, Rajesh ; Palasí Franco, Antoni ; Pape, Heidi ; Patel, Neepa ; Patel, Prity ; Peball, Marina ; Peckham, Elizabeth ; Peery, Terry ; Perez, Rafael ; Perez, Jesús ; Petit, Alisa ; Pinkhardt, Elmar ; Poewe, Werner ; Pomies, Elsa ; Preterre, Cecile ; Quinn, Joseph ; Rascol, Olivier ; Remy, Philippe ; Richard, Irene ; Roeben, Benjamin ; Ruether, Emily ; Rumpf, Jost-Julian ; Russell, David ; Salhi, Hayet ; Samaniego-Toro, Daniela ; Samier-Foubert, Alexandra ; Sánchez, Antonio ; Schmitt, Emmanuelle ; Schnitzler, Alfons ; Schorr, Oliver ; Schwartzbard, Julie ; Schweyer, Kerstin ; Seppi, Klaus ; Sergo, Victoria ; Shill, Holly ; Siderowf, Andrew ; Simuni, Tanya ; Spampinato, Umberto ; Sriram, Ashok ; Stover, Natividad ; Tanner, Caroline ; Tarakad, Arjun ; Taylor, Carolyn ; Thalamus, Claire ; Toothaker, Thomas ; Van Blercom, Nadege ; Vanegas-Arrogave, Nora ; Vela, Lydia ; Vergnet, Sylvian ; Vidal, Tiphaine ; Vöglein, Jonathan ; Walsh, Ryan ; Waters, Cheryl ; Wegscheider, Mirko ; Weidinger, Endy ; Weill, Caroline ; Wenzel, Gregor ; Witjas, Tatiana ; Wurster, Isabel ; Wright, Brenton ; Zimmermann, Milan ; Zuzuarregui, Rafael ; Abt, Markus ; Bamdadian, Atieh ; Barata, Teresa ; Barbet, Nicholas ; Belli, Sara ; Boess, Frank ; Bonni, Azad ; Borroni, Edilio ; Boulay, Anne ; Britschgi, Markus ; Chague, Jerome ; Cosson, Valerie ; Czech, Christian ; Deptula, Dennis ; Diack, Cheikh ; Doody, Rachelle ; Dukart, Juergen ; D'Urso, Giulia ; Dziadek, Sebastian (F. Hoffmann-La Roche) ; Eddleston, Hannah ; Edgar, Chris ; Essioux, Laurent ; Farell, Morgan ; Finch, Rebecca (Roche Products Ltd) ; Fontoura, Paulo ; Gruenbauer, Waltraud ; Hahn, Andreas ; Holiga, Stefan (F. Hoffmann-La Roche) ; Honer, Michael ; Jadidi, Shirin ; Johnson-Wood, Kelly ; Keller, Markus ; Kilchenmann, Timothy ; Koller, Martin ; Kremer, Thomas ; Kustermann, Thomas (F. Hoffmann-La Roche) ; Landsdall, Claire ; Lindemann, Michael (F. Hoffmann-La Roche) ; Lipsmeier, Florian ; Luzy, Cecile ; Manchester, Marianne ; Marchesi, Maddalena ; Martenyi, Ferenc ; Martin-Facklam, Meret ; Mironova, Katerina ; Monnet, Annabelle (F. Hoffmann-La Roche) ; Moore, Emma ; Ness, Daniel K. ; Niggli, Markus ; Nikolcheva, Tania (F. Hoffmann-La Roche) ; Ostrowitzki, Susanne ; Passmard, Benedicte ; Poirier, Agnes ; Post, Anke ; Prasad, Megana ; Pross, Nathalie (F. Hoffmann-La Roche) ; Quock, Tiffany ; Rose, Ellen ; Sarry, Christoph ; Schubert, Christine ; Selkoe, Dennis ; Sevigny, Jeff ; Sink, Kaycee ; Staunton, Hannah ; Steven, Tim ; Strasak, Alexander ; Svoboda, Hanno ; Tripuraneni, Radhika ; Trundell, Dylan ; Umbricht, Daniel ; Verselis, Lynne ; Vogt, Annamarie ; Volkova-Volkmar, Ekaterina ; Weber, Cornelia ; Weber, Silke ; Zago, Wagner (Prothena Biosciences Inc. (San Francisco))
Background: Currently available treatments for Parkinson's disease (PD) do not slow clinical progression nor target alpha-synuclein, a key protein associated with the disease. Objective: The study objective was to evaluate the efficacy and safety of prasinezumab, a humanized monoclonal antibody that binds aggregated alpha-synuclein, in individuals with early PD. [...]
2021 - 10.3389/fneur.2021.705407
Frontiers in neurology, Vol. 12 (january 2021) , p. 705407  

Articles : 21 records found   1 - 10nextend  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.